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Abstract 
Transfected cell arrays (TCAs) represent a high-through-
put technique to correlate gene expression with functional 
cell responses. Despite advances in TCAs, improvements are 
needed for the widespread application of this technology. 
We have developed a TCA that combines a two-plasmid sys-
tem and dual-bioluminescence imaging to quantitatively nor-
malize for variability in transfection and increase sensitivity. 
The two-plasmids consist of: (i) normalization plasmid pres-
ent within each spot, and (ii) functional plasmid that varies 
between spots, responsible for the functional endpoint of the 
array. Bioluminescence imaging of dual-luciferase reporters 
(renilla, firefly luciferase) provides sensitive and quantitative 
detection of cellular response, with minimal post-transfec-
tion processing. The array was applied to quantify estrogen 
receptor  (ER) activity in MCF-7 breast cancer cells. A plas-
mid containing an ER-regulated promoter directing firefly 
luciferase expression was mixed with a normalization plas-
mid, complexed with cationic lipids and deposited into an 
array. ER induction mimicked results obtained through tra-
ditional assays methods, with estrogen inducing luciferase 
expression 10-fold over the antiestrogen fulvestrant or vehi-
cle. Furthermore, the array captured a dose response to es-
trogen, demonstrating the sensitivity of bioluminescence 
quantification. This system provides a tool for basic science 
research, with potential application for the development of 
patient specific therapies. 
Keywords: transfected cell array, bioluminescence imaging, 
substrate-mediated gene delivery, estrogen receptor, breast 
cancer 
Introduction 
Analysis of multiple pathways or genes in a parallel for-
mat can be achieved using a transfected cell array, a high-
throughput technique to correlate gene expression with 
functional cell responses, based on gene delivery from a 
substrate that supports cell adhesion (Bengali et al., 2005; 
Pannier et al., 2005; Segura and Shea, 2002; Segura et al., 
2003). While traditional microarrays can quantify the ex-
pression level of thousands of genes, they cannot accu-
rately describe the functional activity of these genes in a 
cellular and physiological context (Pepperkok and Ellen-
berg, 2006). Transfected cell arrays present a powerful ap-
proach to study gene function in the context of a living 
cell, allowing proteins to be translated and folded cor-
rectly and to interact within the environment of the cell. 
Additionally, a large number of genes can be potentially 
screened in parallel for induction or repression of a given 
function (Palmer and Freeman, 2005). Transfected cell ar-
rays offer compact, economical, and high-throughput 
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analysis in living cells that provides greater consistency 
across assays and facilitates comparisons between con-
ditions, while reducing the amount of reagents and cell 
numbers required, which is an important factor for diffi-
cult to prepare cell types (Hook et al., 2006; Palmer and 
Freeman, 2005). 
Since the original report on transfected cell arrays (Ziaud-
din and Sabatini, 2001), reverse transfection has been em-
ployed in several high-throughput cell based microarrays 
to screen for gene function or activity (8–20). Reverse trans-
fection involves printing mixtures of different plasmids and 
gelatin into specific domains onto a substrate. A lipid-based 
transfection agent is then floated over the array, and cells are 
subsequently seeded to form a living cell microarray of lo-
cally transfected cells in a lawn of nontransfected cells. The 
first transfected cell array was used to analyze genes for 
phosphotyrosine activity and identified six genes; five genes 
that encode known tyrosine kinase proteins and one that en-
codes a protein of unknown function (Ziauddin and Saba-
tini, 2001). Transfected cell arrays have since been applied 
to study signaling pathways (Webb et al., 2003), screen an-
tibody fragments (Delehanty et al., 2004b), identify possi-
ble new lysophosphatidic acid receptors (Lee et al., 2006), 
perform protein localization studies (Hu et al., 2005, 2006), 
screen for proapoptotic genes (Mannherz et al., 2006; Palmer 
et al., 2006), and annotate protein function (Hodges et al., 
2005). The transfected cell array has also been adapted to 
high-throughput RNAi studies (Mousses et al., 2003), specif-
ically for the analysis of spindle formation (Silva et al., 2004), 
secretory pathways (Erfle et al., 2004), and chromosome seg-
regation and nuclear structure in a time-lapse system (Neu-
mann et al., 2006). 
Technological improvements have enhanced the capa-
bilities of the arrays, yet further advancements are required 
for widespread application of this system. Most efforts 
have focused on increasing transfection efficiency within 
the array by using preformed complexes (Delehanty et al., 
2004a, 2004b; Erfle et al., 2004; Hodges et al., 2005; Mousses 
et al., 2003; Pannier et al., 2005; Redmond et al., 2004; Silva 
et al., 2004; Yoshikawa et al., 2004), incorporating fibronec-
tin (Yoshikawa et al., 2004), atelocollagen (Honma et al., 
2001), and recombinant proteins (Redmond et al., 2004) 
with plasmid or DNA complexes, manipulating substrate 
hydrophobicity (Delehanty et al., 2004a), or coating cat-
ionic polymer and collagen onto surfaces prior to transfec-
tion (Chang et al., 2004). Micropatterning strategies have 
also been used to fabricate arrays with improved trans-
fection, using self-assembled monolayers to pattern DNA 
(Pannier et al., 2005; Yamauchi et al., 2004a) or siRNA (Fuji-
moto et al., 2006) complex immobilization on gold slides or 
electrodes (Yamauchi et al., 2004b, 2005). Arrays have been 
formed with dendrimers (How et al., 2004) and viral vec-
tors (Bailey et al., 2006; Hobson et al., 2003; Michiels et al., 
2002) for enhanced gene delivery, magnetic beads (Isalan 
et al., 2005) or hydrogels (Peterbauer et al., 2006) to local-
ize cells and vectors, and for alternative cell types, includ-
ing Drosophila (Wheeler et al., 2004) and nonadherent cells 
(Kato et al., 2004). Further improvements are needed to ac-
commodate issues with transfection efficiency, spot-to-spot 
variability, normalization, post-transfection processing, 
sensitivity, image acquisition and quantification, cell types 
that are difficult to transfect, as well as to expand the bio-
logical endpoints. 
In this report, we combine a two-plasmid system and 
dual-bioluminescence imaging (Pichler et al., 2005; Rafiq 
et al., 1998; Rutter et al., 1998) to quantify array output, 
normalize for variability in transfection efficiency, and ad-
dress sensitivity concerns to overcome known shortcom-
ings of the transfected cell arrays. Soft lithography prin-
ciples (Xia and Whitesides, 1998) were used to create the 
transfected cell array, in which a rubber mold was used 
to confine deposition of preformed DNA complexes to 
designated regions of the substrate and pattern transfec-
tion upon cell seeding. Larger spot sizes were employed 
in the array to provide sufficient numbers of transfected 
cells and increase the reliability and statistical relevance 
of quantitative data obtained from each spot (Fujimoto 
et al., 2006; Hodges et al., 2005). To account for inherent 
variances in transfection between spots, transfection effi-
ciency and protein production were normalized with the 
addition of a second plasmid within all spots of the array, 
encoding renilla luciferase driven by a constitutive pro-
moter, in addition to a primary regulated plasmid report-
ing on the activation of a transcription factor through fire-
fly luciferase expression. Bioluminescence imaging of the 
two luciferase reporters allows for quick image acquisi-
tion with no post-transfection processing. 
We illustrate the utility of the array to quantitatively 
assay for the activity of a transcription factor in response 
to various activators or inhibitors. The estrogen recep-
tor a (ER) pathway in ER-positive, estrogen-responsive 
breast cancer cells was analyzed in an array format, using 
an ERE-regulated promoter reporter system. ER expres-
sion is an important biomarker for determining treatment 
course for clinical breast cancer (Ariazi et al., 2006; Pearce 
and Jordan, 2004). Estrogens, via ER, act as potent mito-
gens of ER-positive breast cancer (Ikeda and Inoue, 2004). 
In our plasmid system, the ER-regulated promoter directs 
firefly luciferase expression in response to transcriptional 
activation by 17β-estradiol (E2)-bound ER. Biolumines-
cence imaging was employed to quantify luciferase-based 
light emission resulting from the ER-regulated and nor-
malization plasmids. The array can thus be employed to 
analyze the induction and inhibition of the transcription 
factors, which could be used in a high-throughput format 
to elucidate gene function and cellular pathways respon-
sible for diseases (Hook et al., 2006; Palmer and Freeman, 
2005; Pepperkok and Ellenberg, 2006). 
Materials and Methods 
Cells 
All studies used ER-positive MCF-7/WS8 mammary carci-
noma cells, clonally derived from MCF-7 cells by selection 
for sensitivity to growth simulation by E2 (Jiang et al., 1992; 
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Levenson and Jordan, 1997). Cells were cultured in fully es-
trogenized, phenol red-containing RPMI-1640 media sup-
plemented with 10% fetal bovine serum (FBS), 100 μM non-
essential amino acids, 100 U antibiotic/antimycotic, 2 mM 
l-glutamine, and 6 ng/ml insulin and maintained at 37°C 
in a humidified 5% CO2 atmosphere. Prior to transfecting 
cells for an experiment, cells were cultured under estrogen-
free conditions by substituting phenol red-free RPMI-1640 
and dextran-coated charcoal-treated FBS in the medium. 
For experiments in which transfected cells were assayed in 
24-well plates using a luminometer, or imaged in arrays us-
ing a CCD camera, cells were cultured under estrogen-free 
condition for 4 days or 18 h, respectively, prior to seeding. 
Culture in estrogen-free media for either time period al-
lowed adequate time for up-regulation of ER protein levels 
due to E2 withdrawal (data not shown), while the shorter 
culture period enhanced cell viability in the array. All me-
dia and media components were purchased from GIBCO/
Invitrogen (Carlsbad, CA). 
Plasmids 
Plasmids were purified from bacteria culture using Qia-
gen (Valencia, CA) reagents and stored in Tris–EDTA buf-
fer solution (10 mM Tris, 1 mM EDTA, pH 7.4) or water at 
–20°C. Plasmid pEGFP-LUC encodes both the enhanced 
green fluorescent protein (EGFP) and firefly luciferase pro-
tein, under the direction of a CMV promoter (Clontech, 
Mountain View, CA). Plasmid pLUC encodes the firefly lu-
ciferase gene in the pNGVL1 (National Gene Vector Labs, 
University of Michigan) vector backbone with a CMV pro-
moter. Estrogen-responsive plasmid pERE(3×)TK-ffLUC 
(Catherino and Jordan 1995) contains three tandem cop-
ies of the palindromic estrogen response element (ERE) se-
quence, placed upstream of a minimal herpes simplex thy-
midine kinase (TK) promoter, directing expression of the 
firefly luciferase coding sequence in response to transcrip-
tional activation by estradiol (E2)-bound ER, followed by 
recruitment of cofactor complexes and basal transcriptional 
machinery. Plasmid pTK-rLUC (phRL-TK, Promega, Mad-
ison, WI) contains the minimal TK promoter driving ex-
pression of a humanized renilla luciferase and was used 
for normalization of the firefly luciferase plasmids. Plasmid 
pβGAL encodes for nuclear-targeted β-galactosidase in the 
pNGVL1 (National Gene Vector Labs, University of Michi-
gan) vector backbone with a CMV promoter and was used 
for control spots on the array. 
DNA Complex Formation 
DNA complexes were formed with Lipofectamine 2000 
(Invitrogen), Lipofectamine LTX (Invitrogen) or Effectene 
(Qiagen), following manufacturer’s instructions. Briefly, 
for both Lipofectamine 2000 and Lipofectamine LTX, DNA 
complexes were formed at a DNA/lipid ratio of 1:2 in se-
rum-free, Opti-MEM media (Invitrogen), by adding trans-
fection reagent diluted in media dropwise to DNA in me-
dia, mixing by gentle pipeting, and then incubating for 20 
min. Effectene complexes were formed by diluting DNA 
into EC buffer, to which the Enhancer buffer was added 
at a DNA to Enhancer ratio of 1:8. After 2–5 min of incu-
bation at room temperature, the Effectene transfection re-
agent was then added to the DNA/Enhancer mixture at a 
DNA to Transfection reagent ratio of 1:4. After incubation 
at room temperature for 10 min, complexes were diluted 
with serum-free media before addition to surfaces or cells. 
DNA in complexes containing multiple plasmids was ex-
tensively mixed prior to complex formation. For induction 
studies in estrogen-free media, phenol red-free Opti-MEM 
media was used for complex formation. 
Multiwell Dish Format Reporter Gene Assays 
Multiwell dish format reporter gene assays were per-
formed to compare the ability of surface delivery of com-
plexes to monitor ER response in comparison to tradi-
tional bolus delivery. For surface delivery, the surface of 
wells of a 24-well plate (Becton Dickinson, Franklin Lakes, 
NJ) were serum coated by incubation with dextran-coated 
charcoal-stripped FBS (10% in 1 ×  PBS, pH 7.4, 380 μL) for 
18 h at 4°C, followed by two wash steps with PBS (Ben-
gali et al., 2005). Complexes were then immobilized follow-
ing complex formation, as described above, by incubation 
of DNA complexes (475 μL) with the serum-coated wells 
for 2 h. After complex incubation, the wells were washed 
twice with Opti-MEM (for Lipofectamine 2000 complexes) 
or EC buffer (for Effectene complexes) and 250,000 MCF-7 
cells (which had been cultured in estrogen-free media for 4 
days) were seeded onto the immobilized DNA-lipid com-
plexes in each well. 
For bolus delivery, MCF-7 cells, which had been cul-
tured in estrogen-free media for 4 days, were seeded in 
estrogen-free medium into 24-well plates at densities of 
125,000 cells per well. Eighteen hours later, complexes, 
formed as described above, were diluted in antibiotic-free, 
estrogen-free media and then added to the cells. 
For both surface and bolus delivery, complexes con-
tained both the pERE(3×)TK-ffLUC plasmid and the nor-
malization plasmid, pTK-rLUC, at a ratio of 4:1. Total 
DNA amounts added for surface delivery ranged from 0.13 
to 1.32 μg/cm2 (0.25–2.5 μg per well) and 0.05 to 0.26 μ/
cm2 (0.025–0.5 μg per well) for bolus delivery. Given bind-
ing profiles, these ranges result in approximately the same 
amount of DNA bound to the surface as delivered as a bo-
lus (Bengali et al., 2005). 
Immediately after complex addition for bolus delivery 
and 4 h after cell seeding for surface delivery, cells were 
treated with combinations of E2 (Sigma–Aldrich, St. Louis, 
MO), the complete anti-estrogen fulvestrant [(FUL), also 
termed ICI 182,780, Tocris Bioscience, Ellisville, MO] or 
vehicle controls. E2 and FUL were both dissolved in etha-
nol and diluted in estrogen-free media to obtain the indi-
cated concentrations (10–12 to 10–9 M for E2; 10–6 M for FUL) 
prior to addition to cells. Ethanol diluted in estrogen-free 
media served as the vehicle control. Cells were harvested 
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and assayed for firefly and renilla luciferase reporter gene 
activities 48 h after transfection using the Dual- Lucifer-
ase Reporter assay system (Promega). In this dual-lucif-
erase system, firefly and renilla luciferases are measured 
sequentially, in a single well. These measurements are ac-
complished by adding the firefly luciferase substrate first, 
measuring luminescence, and then adding reagents that 
quench the firefly luciferase reaction and simultaneously 
provide the renilla luciferase substrate, followed by mea-
suring renilla luciferase activity. The dual-luciferase assays 
were carried out using an automated microplate luminom-
eter equipped with dual-injection ports (Mithras LB 940, 
Berthold Technologies, Oak Ridge, TN). Relative dual-lu-
ciferase activity was calculated by dividing the lumines-
cent signal from the firefly reporter gene by the renilla lu-
minescent signal. 
Array Fabrication 
Soft lithography techniques were used to pattern DNA 
complex deposition. A polydimethylsiloxane (PDMS) 
mold was fabricated by curing PDMS into thin, flat disks. 
Briefly, PDMS was prepared in a 10:1 (v/v) ratio of Sili-
cone Elastomer-184 and Silicone Elastomer Curing Agent-
184 (Sylgard 184, Dow Corning, Midland, MI) by mixing 
the base and curing agent at least 50 times using a syringe 
mixing system. After allowing all air bubbles to escape, 
the PDMS was poured directly into a polystyrene tissue 
culture dish (100 mm, Corning, Corning, NY) and cured 
at 60°C for approximately 2 h. The cured PDMS was re-
moved from the dish and rods of precise diameters were 
then used to punch holes into the PDMS, with diame-
ters of 2.4 mm. The PDMS mold was rinsed in 70% eth-
anol, oxidized using oxygen plasma and then reversibly 
sealed to polystyrene microscope slides (Nunc, Roches-
ter, NY), which were fitted into custom-fabricated Teflon 
slide holders. The holes in the PDMS mold, termed mi-
crowells, served as reservoirs for deposition of DNA com-
plexes onto the polystyrene slide. After 2 h of complex de-
position in humid conditions, the PDMS mold was peeled 
away from the polystyrene, and the slide was rinsed thor-
oughly with Opti-MEM. For all array studies, DNA con-
centrations ranged from 0.007 to 0.021 μg/μL, with 2.2 to 
4 μL of complex volume added to the microwells of the 
PDMS mold. 
To visualize DNA complex immobilization on the ar-
ray and verify deposition replicated the pattern of the mi-
crowells in the PDMS mold, plasmid (pEGFP-LUC) was la-
beled with tetramethyl rhodamine (Label IT Nucleic Acid 
Labeling Kit, Mirus, Madison, WI), complexed as described 
above, and deposited in the microwells. After deposition, 
PDMS removal and rinsing, the resulting spots were visu-
alized with fluorescence microscopy (see below). 
Transfection of cells on the array was verified by depos-
iting complexes formed with plasmid pEGFP-LUC in the 
microwells, as described above, and imaging with fluo-
rescence microscopy. After complex deposition, PDMS re-
moval and rinsing, MCF-7 cells were seeded onto the slide 
at a density of 106 cells per slide (18.75 cm2). Transfection 
was analyzed after 24 and 48 h and characterized through 
GFP expression. Transfected cells were visualized using an 
epifluorescence microscope (Leica; Bannockburn, IL) with 
a FITC filter and equipped with a digital camera. Trans-
fection, as assayed through bioluminescence imaging, was 
verified by depositing complexes containing both pLUC 
and pTKrLUC plasmids, at a 1:1 ratio. After deposition, 
PDMS removal and rinsing, cells were seeded as described 
above. Transfection was analyzed after 24 h and character-
ized by dual-luciferase expression through light emission 
(see below). 
For induction studies in the array, complexes formed 
with different plasmids were immobilized in different 
spots of the array, in triplicate. Briefly, complexes were 
formed with pLUC, pERE(3×)TK-ffLUC, pERE(3×)TK-
ffLUC and pTK-rLUC (2:1 ratio), or pβGAL. After deposi-
tion, PDMS removal and rinsing, MCF-7 cells, which had 
been cultured in estrogen-free media for 18 h, were seeded 
in estrogen-free medium on arrays at a density of 106 cells 
per slide. Immediately after cell seeding, cells were treated 
with combinations E2, FUL, or vehicle control, as described 
above. Dual-luciferase levels were analyzed 24 h later by 
bioluminescence imaging. 
Bioluminescence Imaging 
Expression of both luciferase reporter genes was assessed 
through imaging of light production upon sequential ad-
dition of the luciferase substrates to the bulk media. Bio-
luminescence imaging of the array was performed using 
an IVIS imaging system (Xenogen Corp., Alameda, CA), 
which utilizes a cooled CCD camera. For imaging, ViviRen 
(Promega), a modified renilla luciferase substrate, was di-
luted to 0.66 mM in serum-containing media and then 
added to the arrays at a final concentration of 10 μM. Af-
ter 2 min, the arrays were placed into a light-tight cham-
ber and bioluminescence images were acquired for a total 
exposure time of 1 min. Immediately following imaging 
with ViviRen, 1 mM d-luciferin (Molecular Therapeutics, 
Inc., Ann Arbor, MI, 20 mg/mL in PBS), the firefly lucif-
erase substrate, was added into the media above the cells 
cultured on the array, and bioluminescence images were 
acquired 3 min later, with 1 min exposure. Gray scale and 
bioluminescence images were superimposed using the 
Living Image software (Xenogen Corp.). A constant size 
region of interest (ROI) was drawn over the spots of the 
array to calculate light signals. The signal intensity was 
reported as an integrated light flux (photons/sec), deter-
mined by IGOR software (WaveMetrics, Lake Oswego, 
OR). The signal due to firefly luciferase was determined 
by subtracting ViviRen signal from the luciferin signal. 
Normalization was accomplished by dividing the firefly 
luciferase signal (luciferin signal minus ViviRen signal, 
Promega) by the renilla luciferase signal (ViviRen signal). 
A renilla signal threshold was set at 3.5E4 photon/sec (2X 
background) to distinguish spots of unreliable signals in-
dicating insufficient transfection. 
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Statistics 
Statistical analysis was performed using JMP software (SAS 
Institute, Inc., Cary, NC). Comparative analyses were com-
pleted using one-way ANOVA with Tukey post-tests, at a 
95% confidence level. Mean values with standard deviation 
are reported and all experiments were performed with a 
minimum sample size of three, performed in replicate. 
Results 
Multiwell Dish Format ERE-Reporter Gene Induction 
Studies 
Multiwell dish format reporter gene assays were performed 
to compare ER-regulated, ERE-dependent transcriptional 
activity in MCF-7 cells transfected via surface-mediated de-
livery of DNA complexes in comparison to traditional bo-
lus delivery (Figure 1). DNA complexes, formed using an 
E2-responsive firefly luciferase reporter plasmid pERE( 
3×)TK-ffLUC and a normalization plasmid pTK-rLUC en-
coding renilla luciferase, were delivered to cells via bolus 
or surface delivery. Transfected cells were treated with var-
ious combinations of the agonist E2, the complete antiestro-
gen FUL, or ethanol. Surface delivery of the plasmids (Fig-
ure 1B) resulted in E2-stimulated responses similar to bolus 
delivery (Figure 1A), with E2 statistically inducing fire-
fly luciferase expression six- to sevenfold (P < 0.001) over 
vehicle control or the addition of FUL. Hence, the physio-
logic state of the cells during surface-mediated delivery al-
lowed the cells to transcriptionally respond to E2. Further, 
the maximal induction of reporter gene activity was similar 
whether the DNA complexes were delivered via bolus or 
surface-mediated techniques. 
The amount of transfected plasmid was subsequently 
investigated, which indicated a similar DNA mass-depen-
dent effect in reporter gene activity for both surface and 
bolus-mediated transfection methods (Figure 2). For bolus 
delivery (Figure 2A), all DNA amounts resulted in signif-
icantly different responses (P < 0.01), except for 0.11 and 
0.2 μg/cm2, which were not statistically different from 
each other. Maximal induction was achieved at 0.13 μg/
cm2 (0.25 μg per well). For surface delivery (Figure 2B), all 
DNA amounts resulted in significantly different responses 
(P < 0.05), with 1.05 μg/cm2 (2 μg per well) corresponding 
to the highest induction by E2. These results indicate that 
sufficient amounts of DNA must be transfected for optimal 
reporter gene activity, and excess amounts of DNA lead to 
less efficient reporter gene activity, possibly due to toxicity, 
for both delivery methods. 
Assuming that approximately 20% of DNA added to the 
cell culture dish surface is immobilized (Bengali et al. 2005), 
the condition with the highest induction (1.05 μg/cm2), 
would have presented approximately 0.21 μg/cm2 of DNA 
to the cells, which is higher than the bolus condition with 
the highest induction (0.13 μg/cm2), but still in the range of 
robust activity. Therefore, surface delivery required more 
DNA added to the surface than what would have been ex-
Figure 1. Multiwell dish format reporter gene assay to compare surface delivery to traditional bolus delivery. Surface delivery (B) 
of ERE reporter plasmid system (pERE(3×)TK-ffLUC and normalization plasmid pTK-rLUC) resulted in E2-stimulated transcrip-
tional responses in MCF-7 breast cancer cells similar to bolus delivery (A), reported as a ratio of firefly to renilla luciferase, with E2 
statistically inducing firefly luciferase expression six- to seven-fold over vehicle control or the addition of FUL. (Columns labeled 
with same letter designate conditions not statistically different; all other comparisons, P < 0.001).   
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pected given binding profiles (Bengali et al. 2005). The re-
quirement for more DNA may be due to lower than antici-
pated binding efficiencies (~10%, but still within the range 
of profiles reported). 
The specific transfection reagent used to form DNA com-
plexes, and E2 concentration responses were subsequently 
investigated to determine the applicability and sensitivity 
of the reporter system (Figure 3). For Lipofectamine 2000-
DNA complexes (Figure 3A), E2-induction profiles were 
not significantly different using bolus versus surface deliv-
ery (Figure 3A), with E2 eliciting a concentration response 
from 10–12 to 10–10 M (P < 0.05), and maximal responsive-
ness observed from 10–10 to 10–9 M E2 (P > 0.05) for both 
delivery methods. For Effectene complexes (Figure 3B), bo-
lus delivery resulted in statistically higher levels of ERE 
induction (P < 0.05) than surface delivery for all concen-
trations of E2, except control. However, the level of ERE in-
duction for surface-mediated delivery was similar whether 
Figure 3. The effect of complexing agent and E2 dose response on the ERE reporter plasmid system (pERE(3×)TK-ffLUC and nor-
malization plasmid pTK-rLUC). Bolus and surface delivery of Lipofectamine 2000 complexes (A) resulted in induction profiles 
that were not statistically different from each other, for each concentration of E2. Bolus delivery of Effectene complexes (B) re-
sulted in statistically higher induction (P < 0.05) than surface delivery for all concentrations of E2, except control, however surface 
delivery resulted in more statistically different induction responses. (Columns labeled with same letter designate conditions are 
not statistically different; all other comparisons, P < 0.05.)  
Figure 2. The effect of DNA amount on E2 activation of ERE reporter plasmid system (pERE(3×)TK-ffLUC and normalization 
plasmid pTK-rLUC) delivered to MCF-7 breast cancer cells. Total amount of DNA added to the surface (B) or delivered as a bo-
lus (A), in the presence of 10–9 M E2, resulted in a similar dose-response effect. (Columns labeled with same letter designate condi-
tions not statistically different; all other comparisons, P<0.01 for (A), P < 0.05 for (B).) 
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complexing DNA with Effectene (Figure 3B) or with Lipo-
fectamine 2000 (Figure 2A). Therefore, the particular trans-
fection reagent used affected transcriptional activity via the 
conventional bolus delivery, but not via surface delivery. 
None the less, these results demonstrate that either Effec-
tene or Lipofectamine 2000 can be used to delivery plasmid 
via surface-mediated transfection. Further, other transfec-
tion reagents can likely be adapted for use in surface-medi-
ated delivery. 
Array Fabrication and Verification 
An array was created using soft lithography techniques 
to pattern DNA-lipid complex deposition and subsequent 
transfection upon cell seeding (Figure 4). Briefly, a PDMS 
mold with microwells (Figure 4A) was reversibly sealed 
to polystyrene microscope slides (Figure 4B), with the mi-
crowells serving as reservoirs for deposition of DNA com-
plexes onto the polystyrene slide (Figure 4C). Rhodamine-
labeled DNA complexes deposited within microwells were 
immobilized to the slide in distinct regions, replicating 
the pattern of microwells in the PDMS mold (Figure 4D–
F). Transfection of MCF-7 cells seeded onto arrays of com-
plexes was determined by GFP expression, and was also 
confined to the patterns (Figure 4G–I). 
Bioluminescence Imaging of the Array 
Arrays formed with complexes containing plasmids encod-
ing firefly and renilla luciferase reporter genes (pLUC and 
pTK-rLUC) were used to verify the ability of biolumines-
cence imaging to detect dual-luciferase expression (Figure 
5). Transfection of MCF-7 cells seeded onto these arrays was 
assayed after 24 h by sequentially adding the renilla and 
firefly luciferase substrates. Following ViviRen addition, 
spot intensities averaged 1.10 × 105 ± 2.56 × 104 photon/sec 
(Figure 5A), which are similar to signals obtained with ar-
rays of only pTK-rLUC plasmid (data not shown). D-Lucif-
erin was subsequently added to the same array, which was 
then imaged to acquire a dual signal (Figure 5B), with av-
erage spot intensities of 3.66 × 106 ± 4.34 × 105 photon/sec. 
Firefly luciferase expression was determined by subtracting 
the initial ViviRen signal from the signal obtained through 
imaging with the D-luciferin. Firefly expression averaged 
3.55 × 106 ± 4.30 × 105 photon/sec, also similar to intensi-
ties obtained with arrays formed with only pLUC plasmid 
(data not shown). After normalization, the firefly luciferase 
signal was 34 ± 8 fold greater than the respective renilla ex-
pression. Timecourse studies revealed that the ViviRen sig-
nal remained constant for 10 min after substrate addition. 
Therefore the firefly luciferase signal could be obtained us-
ing this dual imaging strategy followed by subtraction tech-
niques, given imaging was accomplished within 10 min of 
ViviRen addition (data not shown). Bioluminescence imag-
ing was able to sensitively capture both luciferase signals, 
enabling the same cell population to be analyzed for the ex-
pression of multiple reporter genes. 
Array Format ERE-Reporter Gene Induction Studies 
To assess the ability of the arrays to monitor induction of 
ER transcriptional activity (Figure 6), complexes formed 
with different plasmids were immobilized as an array 
in triplicates as follows: 1. pLUC, 2. no DNA (mock), 3. 
pERE(3×)TK-ffLUC, 4. pERE(3×)TK-ffLUC and pTKrLUC 
(2:1 ratio), and 5. pβGAL. Cells seeded on the arrays were 
treated with combinations of ethanol control (Figure 6A,B), 
10–9 M E2 (Figure 6C,D), or 10–9 M E2 +10–6 MFUL (Figure 
6E,F). Dual-luciferase levels were analyzed 24 h later using 
Figure 4. Array fabrication with soft lithography techniques to pattern DNA-lipid complex deposition and transfection. A 
polydimethylsiloxane (PDMS) mold (A) was reversibly sealed to polystyrene slides (B), so that the holes in the mold, termed mi-
crowells, served as reservoirs for deposition of DNA complexes onto the polystyrene (C). After complex deposition in the mi-
crowells, the PDMS mold was peeled away from the polystyrene slide, which was then rinsed thoroughly. Rhodamine-labeled 
DNA complexes were immobilized on the slide in distinct regions, replicating the pattern of microwells in the PDMS mold (D–F). 
Transfection of MCF-7 cells seeded onto these arrays of patterned complexes on polystyrene slides was also confined to the pat-
terns, as determined by GFP expression (G–I).  



























bioluminescence imaging, by first imaging with ViviRen 
(Figure 6A,C,E), and then imaging each array with d-lucif-
erin (Figure 6B,E,F). Renilla luciferase activity was only de-
tected in cells transfected with pTK-rLUC plasmid (Figure 
6A,C,E, column 4), and not in cells transfected with only 
firefly luciferase-encoding plasmids (Figure 6A,C,E, col-
umns 1 and 3), a control βGAL-encoding plasmid (Figure 
6A,C,E, column 5) or no DNA (Figure 6A,C,E, column 2). 
Accordingly, firefly luciferase activity was only detected 
in cells transfected with pLUC (Figure 6B,D,F, column 1) 
or pERE(3×)TK-ffLUC (Figure 6B,D,F, columns 3 and 4), 
but not in mock or βGAL control transfected cells (Figure 
6B,D,F, columns 2 and 5) These results verify the specificity 
of renilla and firefly luciferase detection in this system. 
As predicted, firefly luciferase activity was detected at 
substantially higher levels in cells transfected with pERE( 
3×)TK-ffLUC and treated with E2 (Figure 6D, columns 
3 and 4) compared to those treated with ethanol (Figure 
6B, columns 3 and 4) or E2 + FUL (Figure 6 F, columns 3 
and 4). In control-treated arrays, spots of highest intensity 
were visualized for pLUC (Figure 6B, column 1), given its 
highly active CMV promoter. Cells transfected with both 
the pERE(3×)TK-ffLUC and pTK-rLUC plasmids (Figure 
6B, column 4) resulted in higher signal intensities in the 
presence of luciferin than cells transfected with only the 
pERE(3×)TK-ffLUC (Figure 6B, column 3), as there was no 
carryover of ViviRen signal in the latter spots of transfected 
cells without pTK-rLUC. For E2 addition to the array, sig-
nal intensities with luciferin increased as compared to the 
control condition for all cells transfected with pERE(3×)TK-
ffLUC plasmids (Figure 6D, columns 3 and 4), indicating 
ER-dependent transcriptional activation of the ERE-regu-
lated plasmid. Expression of the pLUC plasmid was largely 
unaffected by E2 (Figure 6D, column 1). Addition of the an-
tiestrogen FUL to the arrays completely eliminated the 
signal in cells transfected with pERE(3×)TK-ffLUC alone 
(Figure 6F, column 3), or substantially reduced signal in-
tensities in cells transfected with both pERE(3×)TK-ffLUC 
and pTK-rLUC (Figure 6F, column 4), in which the lumi-
nescence that was detected was again due to carryover of 
the ViviRen signal. Therefore, addition of 10–6 M FUL led 
to a complete blockade of ER-stimulated activity by 10–9 
M E2. pLUC expression was also lowered in the presence of 
FUL (Figure 6F, column 1) indicating that some transcrip-
tional elements in the CMV may be indirectly regulated by 
ER, possibly by ER tethering to AP1 and SP1 proteins 
bound directly to DNA in this promoter. 
Average renilla luminescence intensities in cells trans-
fected with pERE(3×)TK-ffLUC and pTK-rLUC plasmids 
(Figure 6A,C,E, column 4) were similar in control and E2 + 
FUL treated cells, but lower in E2 alone treated cells. This 
lower renilla luciferase activity is likely due to competition 
for transcriptional cofactors between the ERE(3×)TK and 
TK-only regulated promoters. Under E2 stimulation condi-
tions, ER transcriptional coregulators and basal transcrip-
tional machinery may be preferentially recruited to ERE-
containing promoters rather than promoters lacking EREs. 
Hence, in cells treated with E2, squelching likely occurs at 
the TK-renilla luciferase promoter due to titrating out of 
limiting transcription factors. 
Induction of the ER-regulated plasmid system in the ar-
ray mimicked results obtained through traditional assays 
methods. Firefly luciferase expression was determined by 
subtracting the ViviRen signal from the signal obtained 
through imaging with the d-luciferin, which was then nor-
malized by the ViviRen signal (Figure 6G). For cells trans-
fected with both the pERE(3×)TK-ffLUC and pTKrLUC 
plasmids (Figure 6, column 4), E2 statistically induced 
dual-luciferase activity 10-fold (P < 0.001) over control or 
FUL conditions (Figure 6G). This robust induction verifies 
that the array can accurately report on the activity of the 
ER transcription factor. The concentration response of E2 
was examined to determine the sensitivity of the reporter 
system in an array format (Figure 7). For arrays with spots 
containing both the pERE(3×)TK-ffLUC and pTK-rLUC 
plasmids, increasing the concentration of E2 statistically in-
creased the induction of firefly luciferase expression (P < 
0.05), capturing the concentration-response of E2 in the in-
duction of this plasmid system. 
Discussion 
Methods to use mammalian cells as suitable screening sys-
tems need to be developed to elucidate gene function and 
cellular pathways responsible for diseases (Grimm, 2004). 
Transfected cell arrays offer an advantage in their ability 
to analyze the expression of genes and the function of pro-
teins in living cells, where the machinery is present to en-
sure correct function of the gene products. These live cell 
Figure 5. Bioluminescence imaging to detect dual-luciferase 
expression in an array format. Transfection of MCF-7 cells 
seeded onto arrays of complexes was assayed after 24 h by se-
quentially adding the renilla and firefly luciferase substrates. 
The renilla substrate, ViviRen (10 μM), was first added into 
the media and the array was imaged to determine pTK-rLUC 
expression (A). d-Luciferin (1 mM) was subsequently added to 
the same array, which was then imaged to acquire a dual sig-
nal (B). Firefly luciferase expression (pLUC) was determined 
by subtracting the ViviRen signal from the signal obtained 
through imaging with the d-luciferin. When normalized, the 
firefly luciferase signal was 34 ± 8 fold greater than the respec-
tive renilla expression. 
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microarrays could provide a method to link gene expres-
sion to functional cell responses, with the potential to im-
pact many aspects of science and medicine. Transfected 
cell arrays have been primarily used for identification of 
gene function (Hodges et al., 2005) and discovery of novel 
genes and proteins (Ziauddin and Sabatini, 2001), and have 
potential utility in emerging applications such as detec-
tion of biological warfare agents and environmental tox-
ins through surface receptors (Delehanty et al., 2004b), 
detection of tumor-associated antigens (Hoeben et al., 
2006), and determination of molecular markers or targets 
(Palmer and Freeman, 2005), prior to the costly develop-
ment of novel diagnostic and therapeutic strategies. With 
many possible applications for transfected cell arrays, tech-
nological advances are needed to improve array accuracy 
and consistency and to facilitate endpoint analysis (Hook 
et al., 2006; Palmer and Freeman, 2005). We have combined 
dual plasmid delivery and bioluminescence imaging to cre-
ate a transfected cell array that allows for normalization of 
transfection, and provides rapid and sensitive quantifica-
tion of the cellular response with minimal post-transfection 
processing. 
In our transfected cell array, we employed a dual plas-
mid system to provide normalization, sensitivity, and 
Figure 6. Arrays to monitor ER induction of transcriptional activity. Complexes formed with different plasmids were immobi-
lized in different spots of the array, in triplicate, as follows: (1) pLUC, (2) none, (3) pERE(3×)TK-ffLUC, (4) pERE(3×)TK-ffLUC 
and pTK-rLUC (2:1 ratio), and (5) pβGAL. Cells seeded on the arrays were treated with combinations of ethanol control (A,B), E2 
(C,D), or E2 + FUL (E,F). Dual-luciferase levels were analyzed 24 h later with bioluminescence imaging, by first imaging with the 
renilla luciferase substrate, ViviRen (A,C,E) and then imaging each array with d-luciferin, the firefly luciferase substrate (B,E,F). 
Induction of the ERE-regulated plasmid system was calculated by normalizing firefly luciferase expression to renilla luciferase ex-
pression (G). Firefly luciferase expression was determined by subtracting the ViviRen signal from the signal obtained through im-
aging with the d-luciferin. For spots containing both the pERE(3×)TK-ffLUC and pTK-rLUC plasmids (column 4), E2 statistically 
induced firefly luciferase expression 10-fold over control or FUL conditions, reported as a ratio of firefly to renilla luciferase (G). 
(Columns labeled with same letter designate conditions that are not statistically different; all other comparisons, P < 0.001.) 



























quantification, which are all intricately related, in part, 
through the transfection efficiency. Spot to spot variabil-
ity in transfection can compromise the ability to quantify 
a response within an array, as sub-maximal responses may 
indicate either a limited effect or simply inefficient or un-
equal delivery. A variance in fluorescence intensity of 
transfected cells (GFP) has been noted between spots of the 
array, which likely correlates with the number of plasmids 
internalized (Hook et al., 2006). Therefore, to enable nor-
malization of transfection efficiency, a two-plasmid system 
consisting of: (i) a normalization plasmid that is present 
within each spot, and (ii) a functional plasmid that varies 
between spots and is responsible for the functional end-
point of the array, was deposited in each spot. Both plas-
mids contain the same TK promoter, which is important 
for normalization, and should allow comparison between 
cell lines on the array. Delivery of two plasmids has been 
shown to result in a majority of cells expressing both re-
porter genes (unpublished observations). To normalize 
with a second plasmid, the efficiency of delivery must be 
sufficient to obtain a signal from each plasmid. This issue 
was addressed using larger spot sizes relative to many pre-
vious reports. Small spot size can contribute to low trans-
fection efficiencies (Palmer and Freeman, 2005), which are 
detrimental because each spot on the array may contain so 
few cells that an insufficient number of cells are transfected 
locally to be statistically informative (Hodges et al., 2005). 
Small spots with low transfection efficiency make image 
acquisition and quantification difficult and lower sensitiv-
ity, which can lead to high false positive and false negative 
rates (Palmer et al., 2006), further demonstrating a need to 
account for efficiency and normalization issues to increase 
the reliability of quantitative data obtained from each spot 
(Fujimoto et al., 2006). To further address issues with trans-
fection efficiency, our array fabrication and normalization 
approach could be compatible with viral delivery (Bailey et 
al., 2006; Hobson et al., 2003; Michiels et al., 2002), however 
a plasmid system is more versatile due to the easier pro-
duction and handling methods. 
Bioluminescence imaging (Rutter et al., 1998) was em-
ployed to quantify the response of the dual plasmids 
within the array, with minimal post-transfection process-
ing and high sensitivity. Endpoint analysis for the arrays 
often requires tagging or staining (Hook et al., 2006) to re-
port gene function, which can require extensive post-trans-
fection processing, such as fixation and immunostaining 
(Lee et al., 2006; Wheeler et al., 2005). The normalization 
and functional plasmids contain renilla and firefly lucifer-
ase reporters respectively, which can both be rapidly quan-
tified in each spot by sequential addition of the respective 
substrates to the culture media followed by imaging of the 
array. Luciferase reporters are known to be more sensi-
tive than GFP, without the issues of autofluorescence and 
background signals (Rutter et al., 1998). Luciferase is more 
quantitative and allows for small differences in expression 
to be determined, which enabled our system to determine a 
dose response to an external stimulus. An additional poten-
tial advantage, the short half-life of luciferase could allow 
for real-time imaging to follow the dynamics of gene activ-
ity (Rutter et al., 1998). However, alternative imaging sys-
tems requiring automated microscopy and image process-
ing (Pepperkok and Ellenberg, 2006; Wheeler et al., 2005) 
can allow for detection of changes in cellular morphology 
and cellular level data, which is not possible with biolumi-
nescence imaging. 
The array was used to quantify the activity of the ER 
in breast cancer cells with an ERE-regulated promoter re-
porter system, as an example of an inducible plasmid sys-
tem in a cancer model. ER, a member of the nuclear re-
ceptor superfamily of transcription factors, activates 
transcription through binding of its ligand, E2. Expression 
of ER is clinically used as a biomarker to determine treat-
ment for breast cancer patients (Ariazi et al., 2006; Pearce 
and Jordan, 2004). However, simple expression of tran-
scription factors like ER does not necessarily reflect path-
way activation, as transcription factor activity is regulated 
through diverse mechanisms (Levine and Tjian, 2003), in-
cluding heteromeric complexes, ubiquitination, methyla-
tion, acetylation, and post-translational modifications such 
as phosphorylation. The transfected cell array allows for 
the determination of transcription factor activity. In the 
case of the ER, we assayed for induction by E2. Induction 
in the array mimicked results obtained through traditional 
luciferase assay methods, with E2 inducing luciferase ex-
pression 10-fold over fulvestrant or vehicle controls. The 
array also captured the varying ER activity in response to 
a range of E2 dosages, further demonstrating the sensitivity 
of the bioluminescence quantification system.  
In summary, this report demonstrates the ability to 
quantitatively assess a transfected cell array using dual bio-
Figure 7. Concentration response of E2 on the ERE reporter 
plasmid system in an array format. For spots containing both 
the pERE(3×)TK-ffLUC and pTK-rLUC plasmids, increas-
ing the concentration of E2 statistically increased the induc-
tion of firefly luciferase expression, verifying a true concentra-
tion-response of E2 in the induction of this plasmid system in 
an array format. (Columns labeled with same letter designate 
conditions that are not statistically different; all other compar-
isons, P < 0.05.) 
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luminescence imaging to enable normalization of transfec-
tion efficiency, while reducing post-transfection processing 
and increasing sensitivity. Additionally, ER activity was 
quantified in a physiologically relevant model of breast 
cancer, indicating the effectiveness of the array system, as 
many of the published arrays have only used HEK293T 
cells, a cell line known to be easily transfected and not ap-
plicable to many relevant biological endpoints or applica-
tions. The dual plasmid system and bioluminescence im-
aging are enabling technologies that, when combined with 
high-throughput arrays involving large numbers of plas-
mids, have the potential to impact basic research in cancer 
and other disciplines through investigation of fundamental 
biological processes (Hoeben et al., 2006). With further ad-
vancements in the transfection of primary cells, transfected 
cell arrays have the potential for use in cancer medicine, to 
classify clinical cancer samples through prognostic profiles 
(Chen and Davis, 2006), to provide novel information re-
garding disease progression, and to identify molecular tar-
gets for patient-specific therapy (Kozarova et al., 2006). 
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